Sight Sciences
SGHT
114 hedge funds and large institutions have $85.1M invested in Sight Sciences in 2026 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 19 closing their positions.
6,850% more call options, than puts
Call options by funds: $139K | Put options by funds: $2K
43% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 30
32% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 19
4.74% more ownership
Funds ownership: 36.97% → 41.71% (+4.7%)
3% more funds holding
Funds holding: 111 → 114 (+3)
45% less capital invested
Capital invested by funds: $155M → $85.1M (-$69.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pathstone Holdings
Englewood,
New Jersey
|
+$9.06M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.28M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.69M |
| 4 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$1.63M |
| 5 |
AP
Americana Partners
Houston,
Texas
|
+$1.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IHAM
Integral Health Asset Management
New York
|
-$3.37M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$1.83M |
| 3 |
Walleye Capital
New York
|
-$1.51M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$1.3M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.05M |
SGHT Hedge Fund Activity: Q1 2026 in Review
114 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Sight Sciences (SGHT) for Q1 2026, worth a combined $85.1M — down 45% from $155M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new SGHT positions and 19 closed out — a net gain of 6 holders — while 43 added to existing stakes and 30 trimmed.
The largest buyer was Pathstone Holdings, adding an estimated $9.06M. The largest seller was Integral Health Asset Management, exiting entirely with an estimated $3.37M sold.
- 114 institutional investors held Sight Sciences (SGHT) as of Q1 2026, up from 111 in Q4 2025.
- Funds reported $85.1M of Sight Sciences stock for Q1 2026, down 45% quarter-over-quarter.
- 25 funds opened new Sight Sciences positions in Q1 2026 and 19 closed out, a net change of +6 holders.
- The largest Sight Sciences buyer in Q1 2026 was Pathstone Holdings, an estimated $9.06M added.
- The largest Sight Sciences seller in Q1 2026 was Integral Health Asset Management, an estimated $3.37M sold.
Based on aggregated 13F filings for Q1 2026.